Cardio Diagnostics Announces Publication of Study Showing That its PrecisionCHD Test Could Save Health Insurers over $113 Million Annually

CHICAGO - Cardio Diagnostics Holdings, Inc. , a leader in the next generation of precision cardiovascular medicine technologies that combine proprietary AI algorithms with epigenetic and genetic...

Related Keywords

Chicago ,Illinois ,United States ,America ,American ,Americans ,Khullani Abdullahi ,Robert Philibert ,David Frisvold ,Cardio Diagnostics Holdings Inc ,American Medical Association ,University Of Iowa Hospitals ,Journal Of American Heart Association ,Department Of Economics ,University Of Iowa ,Nasdaq ,Led Health ,Epigenetic Engine Core Technology ,Laboratory Analyses ,Innovation Technology ,Exchange Commission ,Diagnostics Holdings ,Precision Epigenetic Methods ,Iowa Hospitals ,American Heart ,Medicare Advantage ,Associate Professor ,Current Procedural Terminology ,Proprietary Laboratory Analyses ,Medical Association ,Multimodal Delivery ,Further Increase Access ,Potentially Drive Larger Cost Savings ,Chief Medical Officer ,Cost Efficiency Among Payers ,Provider Led Health ,Artificial Intelligence ,Integrated Genetic Epigenetic Engine ,Core Technology ,Private Securities Litigation Act ,Private Securities Litigation Reform Act ,Current Report ,Risk Factor ,News Publishing ,Markets ,